Letters to the Editor
Cohort study of off-label use of low-dose IL-2 therapy for systemic autoimmune diseases
O. Al Tabaa1, S. Hamroun2, C. Leplay3, O. Fain4, D. Klatzmann5, A. Mekinian6
- Department of Internal Medicine, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.
- Department of Internal Medicine, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.
- Department of Pharmacy, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.
- Department of Internal Medicine, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France.
- Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, and Immunology-Immunopathology-Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
- Department of Internal Medicine, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France. arsene.mekinian@aphp.fr
CER14942
2022 Vol.40, N°9
PI 1809, PF 1810
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 35616582 [PubMed]
Received: 29/06/2021
Accepted : 13/09/2021
In Press: 10/05/2022
Published: 20/09/2022
